Prescreening Study to Identify Potential Stargardt Participants for ACDN-01 Clinical Trials (STARPATH)
Conditions
Stargardt Disease · Stargardt Disease 1 · Cone Rod Dystrophy · Juvenile Macular Degeneration
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University of San Francisco, San Francisco, California, United States
Vitreo Retinal Associates, Gainesville, Florida, United States
Wilmer Eye Institute at John Hopkins, Baltimore, Maryland, United States
Massachusetts Eye and Ear, Boston, Massachusetts, United States
University of Michigan Kellogg Eye Center, Ann Arbor, Michigan, United States
Cincinnati Eye Institute, Cincinnati, Ohio, United States
Retina Foundation of Texas, Dallas, Texas, United States
Retina Consultants of Texas, Houston, Texas, United States
Study leads
Alia Rashid
Study Director
Ascidian Therapeutics